← All stocks

GENEXIL Genex Infosys Limited

IT Sector

Tk 32.1 as of 2026-11-12 14:04:27

48of 100
Rank 128 of all scored
Data completeness 100%

Score breakdown

Consistency 62
Profitability 43
Solvency 55
Valuation 64

Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method

Why this score

Strengths

  • Consistency Paid a dividend every year (5/5)
  • Profitability Average ROE 15.34% (efficient: above 15%)
  • Valuation Trades near book value (P/NAV 1.33x)

Concerns

  • Consistency EPS rose in only 1 of 4 years (erratic or cyclical)
  • Profitability Net profit shrinking 5.89% a year

Notes

  • Solvency Debt/equity 1.21x (healthy but risky)
  • Valuation P/E 15.81 is fair

Risk flags

  • Category B (low or irregular dividends)
  • Mid cap (Tk 200-1,000 cr)

Valuation

P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety

52-week range

52.9% above the low, 27.4% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.

Quality and growth

ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)

Dividends and safety

Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap

Size, liquidity and ownership

MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %

Shareholding

  • Sponsor/director 26.1%
  • Institution 21.8%
  • Foreign 0%
  • Public 52.1%

Audited history

YearEPS (Tk) NAV/share Net profit (cr)Cash div % Bonus %
20213.2218.22331010
20223.3616.5338112
20233.3219.23864
20242.6220.383230
20252.1722.112610

Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.

Shariah screen (partial)

Business screen and the debt ratio (loans / market cap 90.4%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.

Educational, not investment advice. Verify on DSE and StockNow before making any decision.

GENEXIL: Genex Infosys Limited | Share Analyser